Session Details

C015 Fundamentals of Dermoscopy

Sun, Mar 10, 1:00 PM - 4:00 PM
Room 29B
3 CME Available Course Ticketed
View Map

DESCRIPTION

This session will cover and review the entire spectrum of dermoscopic findings in benign and malignant melanocytic and non-melanocytic neoplasms. The course will review and provide examples of all the major melanoma specific dermoscopic patterns as well as all the major patterns of benign nevi. We will also cover a broad spectrum of the most common non-meloncytic tumors of the skin. This will cover site specific lesions, classic examples as well as difficult lesions and mimickers. In addition to the didactic teaching of dermoscopy, several unknowns sessions will test the attendees on the material covered.

LEARNING OBJECTIVES

1.

Identify melanoma specific dermoscopic features in pigmented lesions.

2.

Identify the most common dermoscopic patterns of benign melanocytic nevi, including dysplastic and Spitz nevi.

3.

Identify dermoscopic features suggestive of malignancy in epithelial tumors of the skin such as basal and squamous cell carcinoma of the skin.

SCHEDULE

1:00 PM

Dermoscopy of benign and malignant non-melanocytic neoplasms

Jason Bok Lee, MD, FAAD

1:45 PM

Dermoscopy of benign acquired and dysplastic nevi

Oriol Yelamos, MD, IFAAD

2:30 PM

Dermoscopy of malignant Melanocytic neoplasms

Pedram Gerami, MD

3:15 PM

Dermoscopy of benign and malignant Melanocytic neoplasms of special site

Jennifer A. Stein, MD, PhD, FAAD

DIRECTOR

Pedram Gerami, MD

Pedram Gerami, MD

SPEAKERS

Jason Bok Lee, MD, FAAD

Jason Bok Lee, MD, FAAD

Jennifer A. Stein, MD, PhD, FAAD

Jennifer A. Stein, MD, PhD, FAAD

Oriol Yelamos, MD, IFAAD

Oriol Yelamos, MD, IFAAD

HANDOUTS

Login to view handouts

DISCLOSURES

Pedram Gerami, MD

Castle Biosciences, Inc – Consultant(Honoraria); DermTech International – Consultant(Honoraria);

Jason Bok Lee, MD, FAAD

No financial relationships exist with ineligible companies.

Jennifer A. Stein, MD, PhD, FAAD

UpToDate, Inc – Other(Patent royalties or other compensation for Intellectual Property Rights);

Oriol Yelamos, MD, IFAAD

Almirall – Consultant(Honoraria), Investigator(Fees), Speaker(Honoraria); ISDIN – Speaker(Honoraria); ISIS Pharma – Consultant(Honoraria), Speaker(Honoraria); Leo Pharma A/S – Advisory Board(Honoraria); Leo Pharma Inc – Speaker(Honoraria); NAOS – Consultant (1099 relationship)(Honoraria); Philogen S.p.A. – Investigator(Fees); Viatris Inc. – Speaker/Faculty Education(Honoraria);